Experts seek more study of diabetes drugs

New diabetes drugs should be tested to see if they increase heart problems, a panel of experts said July 2. The experts are advisers to the U.S. Food and Drug Administration (FDA). They said the FDA should require that the studies begin before the drugs are approved. The studies could be completed after approval. The FDA does not have to do what its advisers suggest, but it usually does. The Associated Press wrote about the panel’s vote July 3. Concerns about one diabetes drug last year drew attention to how the FDA approves these drugs. An analysis found that Avandia may increase heart risks.